Magnetic Nanoparticles in Biomedicine: Clinical Applications Explained

Nanotechnology studies matter at 1-100 nanometers scale. Properties change at nanoscale: color, solubility, melting point, conductivity, and hardness all change, but atomic mass remains constant. Nanomaterials are classified by dimensions: zero-dimensional (particles), one-dimensional (nanowires), and two-dimensional (graphene). Increased surface area to volume ratio and quantum effects explain property changes.

Physical properties of materials can change at the nanoscale. For example, gold changes color from yellow to red/orange/green/blue, and materials that were opaque can become transparent. These changes are physical properties that differ from bulk materials.

Nanotechnology is the science of studying and applying materials at the nanoscale (1-100 nanometers). One nanometer equals 10^-9 meters, smaller than human hair, water molecules, atoms, and sand particles. Nanomaterials exhibit five changed properties: color (gold becomes red/orange/blue), hardness (copper becomes stronger), solubility, electrical conductivity, and melting point. Two main reasons explain these changes: (1) Increased surface area to volume ratio enables faster reactions; (2) Quantum effects cause electrons to behave differently at extremely small scales, revealing new properties not visible at larger scales.

Nanotechnology involves working with materials at the nanoscale (1-100 nanometers). At this scale, materials exhibit fundamentally different properties due to two key factors: (1) Surface area to volume ratio increases dramatically, exposing more atoms to reactions and enhancing reactivity; (2) Quantum confinement effects appear when dimensions approach electron wavelengths (1-2 nm), causing new behaviors like gold nanoparticles appearing red instead of yellow. Nanomaterials are classified by dimensionality: zero-dimensional (all three dimensions nanoscale, e.g., quantum dots), two-dimensional (two dimensions nanoscale, e.g., carbon nanotubes), three-dimensional (all three dimensions nanoscale but composed of nanoscale particles, e.g., nanocomposites), and one-dimensional (one dimension nanoscale, e.g., nanowires).

Nanotechnology deals with parts as small as one billionth of a meter (1 nanometer). The term comes from Greek 'nano' meaning dwarf. One nanometer equals 10^-9 meters, which is 100,000 times smaller than a human hair. Nanomaterials are defined as materials where at least one dimension falls within 1-100 nanometers. When materials reach this scale, their properties change significantly due to two main reasons: (1) Increased surface area-to-volume ratio, which increases reaction rates and solubility, and (2) Quantum effects, which cause unexpected behaviors like gold appearing red instead of yellow. These changes affect both chemical properties (reactivity, solubility) and physical properties (color, hardness, electrical conductivity).

This comprehensive introduction covers the foundational concepts of pharmacology. The course is divided into General Pharmacology (covering fundamental concepts exclusive to pharmacology like pharmacokinetics and pharmacodynamics) and Systemic Pharmacology (dealing with specific body systems). General Pharmacology is further divided into three parts: Pharmacokinetics (what the body does to drugs), Pharmacodynamics (what drugs do to the body), and topics related to drugs including how drugs are made, clinical trials, types of drugs, side effects, and adverse drug reactions. Pharmacokinetics is also known as ADME study, which stands for Absorption, Distribution, Metabolism, and Excretion. Absorption is the process by which a drug crosses cellular barriers to reach systemic circulation. Distribution is how the drug moves from the heart to various organs. Metabolism converts drugs into water-soluble forms so they can be excreted. Excretion removes drugs from the body. Metabolism and excretion together are called elimination. Three primary pharmacokinetic parameters are: Bioavailability (BA) - how much drug enters the blood, Volume of Distribution (VD) - distribution parameter, and Clearance (CL) - power of the body to eliminate a drug. These three parameters are used to calculate other pharmacokinetic parameters like loading dose, maintenance dose, and half-life.

This section details how drugs move through the body and enter cells. After administration, drugs undergo absorption (entering bloodstream from stomach/intestines) and distribution (spreading through blood to target sites). Not all drugs distribute equally; some target specific tissues. Drugs enter cells through four mechanisms: (1) Receptor binding - drugs bind to specific receptors on cell surfaces, (2) Ion channels - drugs pass through protein channels allowing ion flow, (3) Carrier proteins - drugs are transported by specific carrier proteins, and (4) Enzymatic action - drugs are processed by enzymes within or outside cells. Understanding these mechanisms is essential for predicting drug behavior and therapeutic effects.

Pharmacokinetics (PK) encompasses how the body handles drugs through absorption, distribution, metabolism, and excretion. Absorption transfers drugs from administration sites to systemic circulation, where they exist as bound (protein-bound, primarily albumin) and free forms. The free form (typically 10% of total drug) crosses biological membranes to reach tissues. Drugs cross cell membranes through three mechanisms: passive diffusion (down concentration gradient, lipid-soluble, no energy), facilitated transport (carrier-mediated, no energy), and active transport (requires energy and carriers). The pH-partition hypothesis explains absorption based on ionization state: weak acids absorb better in acidic environments (stomach), while weak bases absorb better in alkaline environments (intestine). Multiple factors influence absorption: lipid-water partition coefficient, molecular size, pharmaceutical form, surface area, blood flow, gastric emptying rate, and first-pass metabolism. These principles form the foundation for understanding drug behavior in the body.

Pharmacokinetics encompasses four phases: absorption (entry into bloodstream), distribution (spread throughout body), metabolism (breakdown), and excretion (elimination). Cell membranes consist of phospholipid bilayers with hydrophobic fatty acid cores that repel water. For drugs to cross membranes, they must be fat-soluble. Absorption rate depends on three factors: route of administration (IV bypasses absorption, oral/rectal require membrane crossing), dosage/concentration (higher concentration increases diffusion rate), and lipid solubility. Most drugs are organic molecules classified as weak organic acids (like aspirin) or weak organic bases (like codeine), whose ionization states determine absorption efficiency.

Drug absorption refers to the process by which a drug enters the systemic circulation (bloodstream). After oral administration, a drug tablet must first disintegrate and dissolve before the active ingredient can be absorbed through the gastrointestinal tract. Once absorbed, drugs enter the bloodstream and are distributed throughout the body via blood vessels. Cell membranes are composed primarily of phospholipids arranged in a bilayer structure, creating a barrier that separates the cell's interior from the external environment. For a drug to enter a cell, it must cross this lipid bilayer. The distribution pattern depends on the drug's physicochemical properties, particularly its solubility and ability to cross biological membranes. Drugs must match the polarity of their target environment to distribute effectively and reach their intended target sites.

Gene therapy aims to treat conditions at the fundamental level by permanently altering disease-causing genes. The approach involves adding copies of wild-type (functional) genes or altering genes to produce normal functional proteins. Genetic material is delivered using vectors: non-viral methods (nanoparticles, polymers, liposomes) and viral methods (microinjection, retrovirus, lentivirus, adenovirus). The genetic material enters cells via endocytosis, and based on pH changes, particles are released into the cytoplasm and transported to the nucleus where the gene is expressed. Successful products include Luxturna (eye disorders), Zolgensma (neuromuscular disorders), and Hemgenix (blood cancers). Gene therapy is also called in vivo therapy, delivering genetic material directly into the body using viral or non-viral vectors.

At the heart of gene therapy is the delivery mechanism called a vector, which acts as a vehicle to carry therapeutic genetic material into target cells. The most promising vectors are derived from viruses because they have evolved to efficiently enter cells. In viral gene therapies, pathogenic viral genes can be removed and replaced entirely with engineered therapeutic genes, making them theoretically non-pathogenic and safe for use in patients.

Vectors are delivery systems used in gene therapy to transport therapeutic genetic material into cells, and they are broadly classified into two categories: viral vectors (including retrovirus, adenovirus, and adeno-associated virus) which are highly efficient at cellular entry but require genetic modification to remove viral DNA and insert therapeutic genes, and non-viral vectors (such as lipid nanoparticles and polymer complexes) which offer advantages of large-scale production and reduced host immune response.

Gene therapy uses viral vectors as carriers to deliver genetic material into cells. Viruses are effective because they naturally evolved to enter cells and deliver their genetic material. The most commonly used vectors include adenoviruses (common cold virus), adeno-associated viruses (helper viruses), and retroviruses/lentiviruses. Adenoviruses are constructed by removing pathogenic regions (e1 and e3) and inserting the gene of interest along with a promoter (switch to turn on expression) and stop sequence. When entering cells, the viral DNA is read by cellular machinery, and the promoter signals ribosomes to produce the therapeutic protein. Retroviruses and lentiviruses can integrate DNA into the human genome, providing permanent genetic modification. Adeno-associated viruses are particularly valuable for nervous system cells because they persist long-term without being destroyed.

The genetic material needs help to get where it needs to go, like being wrapped in a package with an address label. This package delivering the genetic material is known as a vector. Typically viruses are used as vectors because they've evolved to be very good at getting into cells.